BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31605605)

  • 1. PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC.
    Zhao Y; Wang Y; Zhao E; Tan Y; Geng B; Kang C; Li X
    Carcinogenesis; 2020 May; 41(3):274-283. PubMed ID: 31605605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.
    Huang K; Fang C; Yi K; Liu X; Qi H; Tan Y; Zhou J; Li Y; Liu M; Zhang Y; Yang J; Zhang J; Li M; Kang C
    Theranostics; 2018; 8(6):1540-1557. PubMed ID: 29556340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
    Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
    BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5.
    Song S; Long M; Yu G; Cheng Y; Yang Q; Liu J; Wang Y; Sheng J; Wang L; Wang Z; Xu B
    J Cell Mol Med; 2019 Oct; 23(10):6755-6765. PubMed ID: 31342628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
    Huang JL; Liao Y; Qiu MX; Li J; An Y
    Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1.
    Cen X; Chen Q; Wang B; Xu H; Wang X; Ling Y; Zhang X; Qin D
    Cell Commun Signal; 2022 Nov; 20(1):191. PubMed ID: 36443833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma.
    Ning L; Li Z; Wei D; Chen H; Yang C
    Cancer Biomark; 2017; 19(1):75-83. PubMed ID: 28269753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
    Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
    Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑187 is an independent prognostic factor in lung cancer and promotes lung cancer cell invasion via targeting of PTRF.
    Peng J; Liu HZ; Zhong J; Deng ZF; Tie CR; Rao Q; Xu W; You T; Li J; Cai CB; Lu Q; Liu W; Zhang Y; Lei ZY
    Oncol Rep; 2016 Nov; 36(5):2609-2618. PubMed ID: 27634346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Di-Ras2 promotes renal cell carcinoma formation by activating the mitogen-activated protein kinase pathway in the absence of von Hippel-Lindau protein.
    Rao H; Li X; Liu M; Liu J; Li X; Xu J; Li L; Gao WQ
    Oncogene; 2020 May; 39(19):3853-3866. PubMed ID: 32161311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
    Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma.
    Cao Q; Ruan H; Wang K; Song Z; Bao L; Xu T; Xiao H; Wang C; Cheng G; Tong J; Meng X; Liu D; Yang H; Chen K; Zhang X
    Int J Oncol; 2018 Jul; 53(1):137-147. PubMed ID: 29749470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma.
    Ding C; Han F; Xiang H; Xia X; Wang Y; Dou M; Zheng J; Li Y; Xue W; Ding X; Tian P
    J Cell Biochem; 2018 Dec; 119(12):10406-10414. PubMed ID: 30129055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3.
    Nie W; Ni D; Ma X; Zhang Y; Gao Y; Peng C; Zhang X
    Int J Oncol; 2019 Feb; 54(2):559-571. PubMed ID: 30483771
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
    Wang LN; Zhu XQ; Song XS; Xu Y
    J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ciRS-7 expression on clear cell renal cell carcinoma progression.
    Zhao YH; Wang Z; Zhang N; Cui T; Zhang YH
    Chin Med J (Engl); 2020 Sep; 133(17):2084-2089. PubMed ID: 32496306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.